| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Astria Therapeutics, Inc. | Chief Scientific Officer | Stock Option (right to buy) | 55,000 | 01 Mar 2022 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| ATXS | Astria Therapeutics, Inc. | 01 Mar 2022 | 1 | $0 | 4 | Chief Scientific Officer | 03 Mar 2022, 18:18 |
| ATXS | CATABASIS PHARMACEUTICALS INC | 02 Jun 2021 | 1 | $0 | 4 | Chief Scientific Officer | 02 Jun 2021, 19:18 |